20 – 23 October 2019
Bioactive Lipids in Cancer, Inflammation and Related Diseases 16th International Conference, St. Petersburg, Florida
- Professor Jesmond Dalli presenting Insights mechanisms elicited by immunoresolvants in the maintenance of homeostasis and the termination of inflammation, Tuesday 22 October
- Dr Romain Colas presenting Pro-Resolving Mediator Profiles in Cerebrospinal Fluid are Linked with Disease Severity and Outcome in Adults with Tuberculous Meningitis, Monday 21 October
- Mr Issa Beegun presenting Maresin 1 regulates peripheral leukocyte responses in patients with chronic eosinophilic nasal polyposis, Monday 21 October
- Ms Roberta De Matteis presenting Pro-resolving mediators mediate the protective actions of aspirin in colitis associated colorectal cancer, Monday 21 October
- Dr Patricia Soares De Souza presenting Enriched marine oil supplements increase peripheral blood SPM concentrations and reprogram host immune responses: A randomized double-blind placebo-controlled study, Monday 21 October
- Mr Esteban Gomez Cifuentes presenting Identification of pro-resolving mediators-based predictive biomarkers to DMARD responsiveness in rheumatoid arthritis, Monday 21 October
- Dr Duco Koenis presenting RvD5n-3 DPA engages GPR101 to promote the resolution of inflammatory arthritis and Escherichia coli infections, Tuesday 22 October
- Dr Lucy Ly presenting MCTR1, MCTR2, and MCTR3 resolve inflammation and protect joints in Inflammatory Arthritis, Monday 21 October
22 November 2019
The London Metabolomics Network Autumn meeting
Professor Jesmond Dalli presenting Establishing a role for immunoresolvents in the maintenance of homeostasis and as diagnostic markers in patient stratification
